Serology describes a profile of declining malaria transmission in Farafenni, The Gambia by van den Hoogen, Lotus L. et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Serology describes a profile of declining malaria transmission in
Farafenni, The Gambia
Citation for published version:
van den Hoogen, LL, Griffin, JT, Cook, J, Sepulveda, N, Corran, P, Conway, DJ, Milligan, P, Affara, M,
Allen, SJ, Proietti, C, Ceesay, SJ, Targett, GA, D'Alessandro, U, Greenwood, B, Riley, EM & Drakeley, C
2015, 'Serology describes a profile of declining malaria transmission in Farafenni, The Gambia' Malaria
Journal, vol 14, 416. DOI: 10.1186/s12936-015-0939-1
Digital Object Identifier (DOI):
10.1186/s12936-015-0939-1
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Malaria Journal
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 16. Jun. 2018
van den Hoogen et al. Malar J  (2015) 14:416 
DOI 10.1186/s12936-015-0939-1
RESEARCH
Serology describes a profile of declining 
malaria transmission in Farafenni, The Gambia
Lotus L. van den Hoogen1*, Jamie T. Griffin2, Jackie Cook1, Nuno Sepúlveda1,3, Patrick Corran1, 
David J. Conway1, Paul Milligan1, Muna Affara4, Stephen J. Allen5, Carla Proietti6, Serign J. Ceesay4, 
Geoffrey A. Targett1, Umberto D’Alessandro1,4, Brian Greenwood1, Eleanor M. Riley1 and Chris Drakeley1
Abstract 
Background: Malaria morbidity and mortality has declined in recent years in a number of settings. The ability to 
describe changes in malaria transmission associated with these declines is important in terms of assessing the poten-
tial effects of control interventions, and for monitoring and evaluation purposes.
Methods: Data from five cross-sectional surveys conducted in Farafenni and surrounding villages on the north bank 
of River Gambia between 1988 and 2011 were compiled. Antibody responses to MSP-119 were measured in samples 
from all surveys, data were normalized and expressed as seroprevalence and seroconversion rates (SCR) using differ-
ent mathematical models.
Results: Results showed declines in serological metrics with seroprevalence in children aged one to 5 years dropping 
from 19 % (95 % CI 15–23 %) in 1988 to 1 % (0–2 %) in 2011 (p value for trend in proportions < 0.001) and the SCR 
dropping from 0.069 year−1 (0.059–0.080) to 0.022 year−1 (0.017–0.028; p = 0.004). The serological data were consist-
ent with previously described drops in both parasite prevalence in children aged 1–5 years (62 %, 57–66 %, in 1988 to 
2 %, 0–4 %, in 2011; p < 0.001), and all-cause under five mortality rates (37 per 1000 person-years, 34–41, in 1990 to 17, 
15–19, in 2006; p = 0.059).
Conclusions: This analysis shows accurate reconstruction of historical malaria transmission patterns in the Farafenni 
area using anti-malarial antibody responses. Demonstrating congruence between serological measures, and con-
ventional clinical and parasitological measures suggests broader utility for serology in monitoring and evaluation of 
malaria transmission.
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Background
Monitoring changes in malaria transmission levels due 
to natural fluctuations or as a result of control pro-
grammes is a key component of disease surveillance. 
There are a number of metrics available to assess malaria 
transmission ranging from passively collected morbid-
ity and mortality data at health facilities to active detec-
tion of parasites in the mosquito and human host from 
field studies. The utility of different measures depends on 
a variety of factors including the capacity of the health 
system to collect and analyse routine clinical data, local 
ecology of vectors and transmission intensity itself [1, 2].
Serological measures based on human anti-malarial 
antibodies can be used to assess malaria transmission 
intensity. Antibodies are produced during an infection 
with the Plasmodium parasite and are boosted upon 
subsequent infections. The presence of Plasmodium-
specific antibody levels reflects exposure and, since many 
antibody responses are longer lived than infections in 
humans, they represent cumulative exposure over time. 
Therefore, anti-malarial antibody responses represent a 
population’s history of malaria transmission [3]. Antibody 
responses can be expressed as age-adjusted continuous 
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or binary variables to generate a seroconversion rate 
(SCR) which is analogous to the force of infection [3]. 
The SCR reflects the rate at which individuals become 
seropositive and can be estimated using simple reversible 
catalytic [3] or superinfection models [4]. The SCR has 
been used to describe malaria transmission intensity [3, 
5], as well as to measure a change in malaria transmission 
[5–8] and to assess the effects of malaria control meas-
ures on transmission [7]. Serological measures are use-
ful additional metrics to measure malaria transmission 
intensity, alongside parasite prevalence (parasite rate, PR) 
in humans and the entomological inoculation rate (EIR), 
especially at low transmission levels where other metrics 
lose their ability to discriminate [1, 9].
There are relatively few examples of repeated surveys 
to examine the validity of serological estimates of trans-
mission over time. Historically, malaria transmission 
has been well-described in The Gambia with significant 
declines in malaria indices over the last 25 years [10–13]. 
Due to a longstanding collaboration between the London 
School of Hygiene and Tropical Medicine (LSHTM) and 
the Medical Research Council (MRC) in The Gambia, 
seroprevalence and PR data, obtained from samples col-
lected in the villages around Farafenni in The Gambia, 
were combined. In Farafenni, on the north bank of the 
River Gambia, malaria was hyperendemic in 1988 with a 
PR over 60 % in children under 15 years of age [14, 15]. 
However, overall dry season microscopy PRs declined 
from 29  % in 1988 [14] to 11  % in 2008 [16]. In order 
to assess the utility of serological measures in describ-
ing this decline of malaria transmission, seroprevalence 
data from the Farafenni area between 1988 and 2011 have 
been compared with PR and previously described mor-
tality rates.
Methods
Study area
Farafenni is situated on the north bank of the River Gam-
bia, approximately 3  km from the border with Senegal 
(Fig.  1). Malaria transmission in the area is highly sea-
sonal with nearly all transmission occurring during and 
after the rainy season [14], characterized by intense rains 
from June to October, with transmission continuing until 
December [10, 17]. Plasmodium falciparum is responsi-
ble for nearly all malaria infections in Farafenni [14, 18].
Data collection and laboratory methods
Original datasets from surveys in 1988, 1990, 2003, 
2008, and 2011, conducted as part of a longstanding col-
laboration between the LSHTM and the MRC in The 
Gambia, were obtained (Table  1). The location of the 
participating villages in the Farafenni area during these 
studies is shown in Fig. 1. A full description of the study 
population, data collection and laboratory methods for 
each survey is detailed elsewhere [14, 16, 19–23].
The enzyme-linked immunosorbent assay (ELISA) 
protocol was the same in all surveys [24] and antibody 
responses to the 19 Kda fragment of P. falciparum mero-
zoite surface protein 1 (MSP-119) were recorded together 
with demographic data (e.g., age, sex) and parasite status. 
ELISAs were performed in The Gambia for all surveys, 
except 1990.
Statistical analyses
All statistical analyses were conducted in Stata (version 
13.1) and Prism (version 6.02). Infants under 1 year of age 
were excluded from each dataset to remove any influence 
of maternally derived antibodies [3]. A two-component 
Gaussian mixture model [25] was used to determine 
separate cut-off values for seropositivity for each data-
set. SCRs (i.e., the rate at which the population becomes 
seropositive) and seroreversion rates (SRR; i.e., the rate at 
which the population reverts back to being seronegative) 
were calculated by fitting four different models. Firstly, 
a simple reversible catalytic model was fitted to age-
adjusted seropositivity data using maximum likelihood 
[3]. Secondly, data were fitted to a superinfection model 
[4] which is comparable to the reversible catalytic model 
but allows for prolonged periods in the seropositivity 
state due to recurrent malaria exposure. More precisely, 
this model assumes that when an individual is re-infected 
while seropositive, the antibody response can be boosted 
and thus individuals can move between multiple seropos-
itive states. Fixing and allowing SRR to vary was inves-
tigated for both of these models; the common SRR was 
estimated using maximum likelihood as described previ-
ously [3]. Furthermore, the presence of specific change 
points in transmission was investigated for each of the 
surveys separately as previously described [5, 7]. A likeli-
hood ratio test was used to determine whether a model 
with a change point in transmission fit the data bet-
ter than a model using one SCR. Finally, the change in 
the SCR was also investigated using an extension of the 
reversible catalytic model that allows multiple changes in 
the SCR, which was fitted to all surveys simultaneously. 
This novel approach can estimate the parameters using 
penalized maximum likelihood, by assuming that the log 
of the ratio of successive SCRs follows a normal distribu-
tion. This assumption results in smoothed estimates of 
the SCR over time, and so the model is referred to here as 
the ‘smoothed model’. The reversible catalytic models are 
implemented as a Stata program called revcat (see Addi-
tional file 1) [26].
Chi-squared was used to test differences between pro-
portions from two surveys while the Wilcoxon–Mann–
Whitney test was applied to continuous outcomes to 
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compare the medians of two independent surveys. The 
trend in previously published all-cause under five-year-
old mortality rates per 1000 person-years (U5MR) for the 
Farafenni area and the SCR estimates over time were cal-
culated with linear regression. The Cochrane-Armitage 
test for trend in proportions was used to test the trend 
in the PR and seroprevalence. PR, U5MR, SRR, as well as 
SCR estimates, are followed by 95 % confidence intervals 
in brackets.
Results
The number of individuals sampled in each survey ranged 
from 488 in 2011 to 742 in 1988, Table 1. The 1988, 1990 
and 2011 surveys were performed during the peak trans-
mission season (October/November), while the 2003 
survey was conducted during the start of the wet sea-
son (July) and the 2008 survey during the early dry sea-
son (January/February). The median age and age range 
were comparable in the 1990–2008 surveys. However, 
the median age was lower in the 1988 survey and the age 
range was lower in the 2011 survey, which only included 
children up to the age of 15  years. Seroprevalence to 
MSP-119 in 1–5 year olds decreased from 19 % (15–23 %) 
in 1988 to 1 % (0–2 %) in 2011 (p < 0.001), while the PR 
in 1–5 year olds declined from 62 % (57–66 %) in 1988 
to 2 % (0–4 %) in 2011 (p < 0.001). When comparing the 
Fig. 1 Map of a Africa, b The Gambia and c the Farafenni area. In b the star represents the capital Banjul and the solid dot represents Farafenni. In c 
the location of the five surveys was as follows: 1988 Kataba hamlets (solid black fill), 1990 Fula hamlets and surrounding villages (dashed lines), 2003 
the catchment area of the Farafenni hospital (solid black line), 2008 Dibba Kunda, Bambali, Sara Kunda and Pallen Wollof (dotted–dashed lines) and 
2011 the Farafenni area (dotted line)
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1988 and 1990 surveys, overall seroprevalence was lower 
(28 vs 46 %, p < 0.001) and human parasite carriage was 
higher (53 vs 16 %, p < 0.001) in 1988, even though both 
surveys were performed in the same season and were 
only 2 years apart. A plausible explanation for this could 
be the younger population in 1988 compared to 1990 
(median age 5 vs 14 years, p < 0.001).
The reversible catalytic and superinfection models led 
to similar results with an overall decrease in the SCR 
between 1988 and 2011 of 67–68 % when the SRR was 
fixed and 74–76 % when the SRR was allowed to vary, 
Table  2. Since both models provided similar results, 
the reversible catalytic model with a fixed SRR was 
used for further analysis. Predicted age seroprevalence 
curves for MSP-119 for each survey are shown in Fig. 2. 
The SCR declined from 0.069  year−1 (0.059–0.080) in 
1988 to 0.022 year−1 (0.017–0.028) in 2011 (p = 0.004), 
Fig. 3. The SCR values suggest a drop in the estimated 
annual EIR from ~5 to ~0.5 infectious bites per person 
per year (ib/p/y) using the previously described rela-
tionship between SCR and EIR [3, 27]. The previously 
published U5MR in the Farafenni area [28] showed 
an overall decline of 54  %; from 37 per 1000 person-
years (34–41) in 1990 to 17 (15–19) in 2006 (p = 0.059; 
Fig. 3).  
When the SRR was allowed to vary across surveys 
it was between 1.7 and 1.9 times as high in the surveys 
in 1988 and 1990 in comparison with the more recent 
surveys in 2003 and 2008 (Table 2). Since only individu-
als under 15 years old were included in 2011, the SRR for 
that year approximated to zero. The SRRs reflect the time 
for a seropositive individual to become seronegative, 
which ranged from ~14–26  years in the earlier surveys 
(superinfection model and reversible catalytic model, 
respectively) to ~27–46 years in the more recent surveys.
Analysis per survey—while fixing the SRR to the pre-
viously determined common SRR (0.028  year−1)—
identified a significant change in transmission 
intensity only in the 2011 survey data and indicated that 
the change occurred in 2006 (5  years previously; range 
4–8; p  <  0.001). A corresponding change point was not 
seen in the 2008 survey (p =  0.179). SCR estimates for 
the 2011 surveys were as follows: 0.002  year−1 (0.000–
0.013) up to the age of 5 and 0.053 year−1 (0.040-0.070) 
for those aged five and over (Fig. 2e). The SCR before the 
change point reflects most recent transmission and sug-
gests an even more pronounced decline in the SCR of 
97 % since 1988. However, since this survey only included 
children, it was decided to use the ‘average’ SCR for 2011 
in the analyses described above.
The smoothed model estimating a separate SCR for 
each two-year period between 1988 and 2012 produced 
similar results to the fixed reversible catalytic model as 
shown in Fig.  3. The SCR declined from 0.067  year−1 
(0.059–0.077) in 1988 to 0.025  year−1 (0.017–0.035) 
in 2012; reflecting an overall decrease of 63  % 
Table 1 General characteristics of the surveyed study population between 1988 and 2011 in Farafenni, the Gambia
For 2011 ‘all ages’ only consists of children up to the age of 15 years
CI confidence interval
a Survey for parasite prevalence performed in November
b Parasite prevalence for P. falciparum as measured by polymerase chain reaction in the 2011 survey and microscopy of blood films in all other surveys
c For age 6 months–5 years
d For age 6 months–15 years
e Seroprevalence for MSP-119
% (95 % CI) 1988 1990 2003 2008 2011
Timing of survey November November Julya January/february October
Season Peak transmission Peak transmission Start wet season Dry season Peak transmission
Median age in years (range) 5 (1–41) 14 (1–90) 11 (1–83) 13 (1–80) 10 (1–15)
Parasite prevalenceb
 1–5 year olds 62 (57–66) 17 (11–23) 39c (31–46) 16 (9–22) 2 (0–4)
 1–15 year olds 60 (56–64) 22 (18–26) 40d (33–46) 18 (14–22) 3 (1–4)
 All ages 53 (49–57) 16 (13–19) 34 (30–38) 13 (11–16) 3 (1–4)
Number sampled for serology 742 736 624 670 488
Seroprevalencee
 1–5 year olds 19 (15–23) 19 (12–25) 12 (7–17) 13 (7–19) 1 (0–2)
 1–15 year olds 23 (20–26) 31 (27–36) 23 (18–27) 20 (16–24) 13 (10–16)
 All ages 28 (25–31) 46 (42–50) 35 (31–39) 34 (30–38) 13 (10–16)
Reference [14, 19] [20, 21] [22] [16] [23]
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(46–75  %). The common SRR in the smoothed model 
was 0.033 year−1 (0.026–0.043), equating to an antibody 
decay time of 30 years.
Discussion
This study describes the retrospective analysis of anti-
body responses to the MSP-119 antigen of P. falciparum 
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Fig. 2 Predicted age-seroprevalence curves for MSP-119 between 1988 and 2011 in Farafenni, The Gambia. MSP-119 seroconversion curves per 
survey using the reversible catalytic model (with a fixed common seroreversion rate across all five surveys: 0.028 year−1). In the separate graphs for 
the five surveys (a–e) solid lines represent the fitted probability for being seropositive to MSP-119, dotted lines represent the 95 % confidence interval 
for these fits and triangles represent the observed proportion of seropositives per age decile. The five separate fits are combined in graph (f)
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malaria in samples collected over a 23-year period in vil-
lages in the Farafenni area, The Gambia. Serological out-
comes showed a clear relation to documented changes in 
malaria transmission with a decline in the seroprevalence 
and the SCR in line with a decline in parasite prevalence 
and all-cause mortality rates in children under 5 years old 
(U5MR).
The data describe very similar decreases over the 
time period in parasite prevalence (from 62 to 2–97  % 
decrease) and seroprevalence (from 19 to 1–95  % 
decrease) in children under 5 years old, while other stud-
ies from this area [23, 25] and elsewhere [29] have typi-
cally observed serological measures to be consistently 
higher than infection measures. Although similar preva-
lence of parasite carriage by PCR and seropositivity has 
been previously described in the Farafenni area [16], the 
reasons for the results in the current study are unclear. It 
may be due to the fact that responses to only one malaria 
antigen were assessed and, therefore, the data represent 
a minimal estimate of seroprevalence. All age seropreva-
lence predictably is higher than infection measures and 
operationally it may be logistically more attractive to 
focus on the whole population rather than specific age 
groups to generate these data. Further analysis is under-
way to examine parasite and serological metrics over a 
much wider geographical range.
Analysis of age-related seroprevalence data col-
lected using both the reversible catalytic [3] and the 
superinfection model [4] gave similar estimates for sero-
conversion irrespective of whether the SRR was fixed or 
allowed to vary across surveys [3]. Estimates from dif-
ferent models suggest a decline in seroconversion of 
approximately 70 % between 1988 and 2011, equating to 
an estimated ten-fold reduction in EIR to less than 1 ib/p/
year. This is consistent with reports of declines in trans-
mission both in The Gambia [12, 13], including Farafenni 
[10, 13], based on a variety of metrics (PR and U5MR), 
and similar declines between 1990 and 2012 reported by 
Trape et al. in nearby Dielmo, Senegal [30]. The reported 
decline in malaria transmission in Farafenni is likely 
related to scale-up of national intervention policies dur-
ing this period (free malaria diagnosis in 1998, the distri-
bution of free bed nets in 2000, intermittent preventive 
treatment in pregnant women in 2002, and the authoriza-
tion of DDT for indoor residual spraying in 2007) [11]. 
Whilst caution should be observed with any extrapola-
tion, data from the linear trend suggest a predicted cur-
rent SCR for 2015 of 0.020  year−1 (0.010–0.030) which 
correlates with an estimated EIR of ~0.4 ib/p/year.
Previous serological analyses of samples from Bioko 
Island, Equatorial Guinea [7] and southern Vanuatu [6] 
have shown a step-change in malaria transmission repre-
senting a distinct drop in exposure to infection after the 
introduction of malaria control methods. This is a unique 
facet of serological measures in that, when integrated 
with age, they allow examination of historical changes in 
exposure to infection. In the current analysis the absence 
of a step phenomenon in the smoothed model, and only 
in the 2011 survey when surveys were analysed sepa-
rately, indicates that transmission reduction has been 
gradual rather than sudden. This may reflect the steady 
increase in intervention delivery, coverage and uptake 
as illustrated in the country profile in the WHO World 
Malaria Report 2014 [11].
The absence of a step-change (before the 2011 sur-
vey) may also be due to the sample sizes being too small 
to detect this phenomenon [31]. A recent serological 
analysis of a longitudinal sample set from Asembo Bay 
in Kenya similarly did not find a distinct drop in trans-
mission associated with the widespread distribution of 
nets in the 1990s despite significant reductions in mor-
bidity and mortality at the time. This was most likely due 
to a combination of limited sample size and a gradual 
decrease in transmission [32]. In the current analysis the 
change point in 2006 (detected in the 2011 survey) cor-
responds with previously reported minimal MSP-119 
responses under the age of ten in 2009 by Ceesay et  al. 
[13]. It suggests an even more pronounced decline in 
the SCR of 97  % since 1988. However, the 2011 data 
presented here included children only up to the age of 
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Fig. 3 Trend in the seroconversion rate, all-cause mortality rate and 
parasite prevalence in Farafenni, The Gambia. Linear regression of 
MSP-119 seroconversion rate (SCR) estimates per survey using the 
reversible catalytic model (with a fixed common seroreversion rate 
across all five surveys: 0.028 year−1; solid circles and solid line), SCR 
estimates per 2 years using the smoothed model (open circles), linear 
regression of all-cause under 5-year-old mortality rate per 1000 
person-years (U5MR) as previously published by Jasseh et al. [28] 
(squares and dashed line), and parasite prevalence (PR) per survey 
(as measured by polymerase chain reaction in the 2011 survey and 
microscopy of blood films in all other surveys; triangles). Survey data 
are from five surveys in the Farafenni area between 1988 and 2011
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15  years and it would have been interesting to analyse 
the full serological profile across all ages to confirm this 
trend.
Interestingly, when the SRR was allowed to vary across 
surveys, it was nearly two-fold higher in the older sur-
veys (1988 and 1990) compared to the more recent sur-
veys (2003 and 2008), suggesting slightly paradoxically 
that the average decay time for antibodies increased 
while malaria transmission decreased. This increase in 
the half-life of anti-malarial antibodies over time might 
be explained by the fact that fewer children are infected 
in recent surveys and thus older individuals with more 
established antibody responses remain. It has previously 
been observed that anti-malarial antibody titres are rel-
atively stable (consisting of long-lived plasma cells after 
repeated exposure) in adults but very variable (consisting 
of short-lived plasma cells) in children [33].
As previously described by Bosomprah et  al. [4] the 
superinfection and reversible catalytic models gave very 
similar estimations of the SCR, yet the time for anti-
malarial antibodies to decay was approximately 1.8 times 
faster in the superinfection model. This gave more real-
istic estimations of the time to decay (approximately 
20  years) in comparison with the previously described 
minimum of 10 years [3]. Although both findings, the 
increased half-life of anti-malarial antibodies following 
declining transmission as well as the  overall decreased 
half-life in the superinfection model, seem valid, further 
research is still needed to assess antibody decay rates in 
relation to age.
The reversible catalytic model was extended to a model 
that allowed fitting all surveys simultaneously and to 
allow multiple SCRs, with a smoothing parameter to pre-
vent over-fitting. This model is particularly useful when 
the trend in the SCR, with a possible change point, is 
analysed from data collected from the same population 
over an extended period of time, and in the current study 
these estimates overlapped well with the reversible cata-
lytic model with a fixed SRR. This will allow more robust 
analyses of data with multiple survey points with a pre-
dictive element for SCR, though this model would benefit 
from testing against other datasets from areas of different 
endemicity and transmission patterns. However, the data 
suggest that the parsimonious reversible catalytic model 
(with the exploration of a possible change point) is robust 
when compared to more involved models and is appro-
priate for studies such as a single cross-sectional survey. 
At high transmission levels, the superinfection model 
would provide additional information. Ideally, a popula-
tion with a broad age range should be used in all of these 
models, since this increases the accuracy of seroconver-
sion estimates [31].
There are a number of caveats to be taken into account 
in interpreting these data. Firstly the serological assays 
for these surveys were conducted at different times and 
by different groups. However, the same ELISA protocol 
was used including the same recombinant protein as tar-
get antigen. Secondly, the five surveys were conducted 
in the same broad geographical area but in different vil-
lages and there is likely to be heterogeneity of transmis-
sion between the villages. The small sample sizes do not 
allow village specific estimates and so only overall SCRs 
are presented to represent population level exposure on 
a larger scale in a similar manner to PR. Additionally, 
surveys were conducted at different times of the year 
and this may have influenced serological profiles. How-
ever, as described above, some anti-malarial antibody 
responses have estimated half-lives of at least 10 years 
[3] and are therefore likely to be stable over shorter peri-
ods of time. This suggests that the seasonal timing of the 
survey should not affect the measurement of exposure, 
as shown in 2008/2009 in The Gambia [34], in contrast 
to point prevalence estimates of PR data. The 2011 sur-
vey included children only up to the age of 15 years and 
this may result in an underestimate of the overall SCR. 
However, this should not influence the observed trend in 
declining transmission significantly. Whilst these surveys 
were not originally conceived for longitudinal analyses 
the use of the same ELISA protocol and target protein 
construct, together with the correlation between the 
decrease in serological profile and decreases in the PR 
and U5MR over nearly 25 years suggests that these data 
are representative of the underlying disease dynamics in 
the study area.
Conclusion
The rationale for this work is that in areas with low 
malaria transmission conventional measures of malaria 
transmission, such as the PR and the EIR, may have lit-
tle discriminative power unless sampling of humans and 
mosquitoes is intense [1, 9, 35]. Serological metrics have 
promise as adjunct measures of transmission [6, 7] but 
for wider use and better understanding of the implica-
tions of these metrics, studies comparing serological 
outcomes with conventional biological and health meas-
ures (disease incidence, mortality, etc.) are required. 
This report documents a decline in anti-malarial specific 
antibodies in Farafenni over a time period of 23  years. 
This decline mirrors the decrease in other malariomet-
ric indices and of the U5MR in the Farafenni area [10, 
12, 13] thereby confirming the suitability and validity 
of serology to monitor long-term changes in transmis-
sion. Anti-malarial antibody decay times in relation to 
age should be further explored, in order to obtain a more 
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comprehensive insight into the immuno-epidemiology of 
(decreasing) malaria transmission.
Authors’ contributions
DC, PM, GT, UD, SC, SA, ER, and BG participated in the design and coordination 
of the separate surveys. CP, MA, JC, and PC carried out the ELISA assays. LH, JG, 
NS, and JC performed the statistical analyses. LH, CD, JG, JC, and ER drafted the 
manuscript and interpreted findings. All authors read and approved the final 
manuscript.
Author details
1 Department of Immunology and Infection, Faculty of Infectious and Tropi-
cal Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, 
London WC1E 7HT, UK. 2 MRC Centre for Outbreak Analysis and Modelling, 
Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial 
College London, London W2 1PG, UK. 3 Centre of Statistics and Applications 
of University of Lisbon, Faculdade de Ciências Da Universidade de Lisboa, 
Bloco C6—Piso 4, 1749-1016 Lisbon, Portugal. 4 Disease Control and Elimina-
tion, Medical Research Council Unit, Fajara 220, The Gambia. 5 Department 
of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool L3 5QA, 
UK. 6 Infectious Diseases Programme, QIMR Berghofer Medical Research Insti-
tute, Brisbane QLD 4029, Australia. 
Acknowledgements
We thank all those who contributed to the field surveys including the Medical 
Research Council (MRC), the staff and the residents of Farafenni area. Further-
more, we would like to thank Jonathan Gillig for serological data analyses. The 
1988 survey was funded by the World Health Organization/TDR and UK MRC. 
CD and NS are funded by the Wellcome Trust Grant Number 091924. NS also 
acknowledges partial funding from Fundação para a Ciência e Tecnologia 
(Portugal) through the project Pest-OE/MAT/UI0006/2011.
Competing interests
The authors declare that they have no competing interests.
Received: 23 July 2015   Accepted: 9 October 2015
References
 1. Tusting LS, Bousema T, Smith DL, Drakeley C. Measuring changes in 
Plasmodium falciparum transmission: precision, accuracy and costs of 
metrics. Adv Parasitol. 2014;84:151–208.
 2. Smith DL, Drakeley CJ, Chiyaka C, Hay SI. A quantitative analysis of trans-
mission efficiency versus intensity for malaria. Nat Commun. 2010;1:108.
 3. Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SLR, Carneiro 
I, et al. Estimating medium- and long-term trends in malaria transmission 
by using serological markers of malaria exposure. Proc Natl Acad Sci USA. 
2005;102:5108–13.
 4. Bosomprah S. A mathematical model of seropositivity to malaria antigen, 
allowing seropositivity to be prolonged by exposure. Malar J. 2014;13:12.
 5. Stewart L, Gosling R, Griffin J, Gesase S, Campo J, Hashim R, et al. Rapid 
assessment of malaria transmission using age-specific sero-conversion 
rates. PLoS One. 2009;4:e6083.
 6. Cook J, Reid H, Iavro J, Kuwahata M, Taleo G, Clements A, et al. Using sero-
logical measures to monitor changes in malaria transmission in Vanuatu. 
Malar J. 2010;9:169.
 7. Cook J, Kleinschmidt I, Schwabe C, Nseng G, Bousema T, Corran PH, et al. 
Serological markers suggest heterogeneity of effectiveness of malaria 
control interventions on Bioko Island, equatorial Guinea. PLoS One. 
2011;6:e25137.
Additional file
Additional file 1. Reverse catalytic models with a constant rate of sero-
conversion and multiple seroconversion rates.
 8. Cook J, Speybroeck N, Sochanta T, Somony H, Sokny M, Claes F, et al. 
Sero-epidemiological evaluation of changes in Plasmodium falciparum 
and Plasmodium vivax transmission patterns over the rainy season in 
Cambodia. Malar J. 2012;11:86.
 9. Bousema T, Okell L, Felger I, Drakeley C. Asymptomatic malaria infections: 
detectability, transmissibility and public health relevance. Nat Rev Micro-
biol. 2014;12:833–40.
 10. Ndugwa RP, Ramroth H, Müller O, Jasseh M, Sié A, Kouyaté B, et al. Com-
parison of all-cause and malaria-specific mortality from two West African 
countries with different malaria transmission patterns. Malar J. 2008;7:15.
 11. WHO. Gambia country profile. Geneva: World Health Organization; 2014.
 12. Ceesay SJ, Casals-Pascual C, Erskine J, Anya SE, Duah NO, Fulford AJC, et al. 
Changes in malaria indices between 1999 and 2007 in The Gambia: a 
retrospective analysis. Lancet. 2008;372:1545–54.
 13. Ceesay SJ, Casals-Pascual C, Nwakanma DC, Walther M, Gomez-Escobar 
N, Fulford AJC, et al. Continued decline of malaria in The Gambia with 
implications for elimination. PLoS One. 2010;5:e12242.
 14. Riley EM, Allen SJ, Bennett S, Thomas PJ, O’Donnell A, Lindsay SW, 
et al. Recognition of dominant T cell-stimulating epitopes from the 
circumsporozoite protein of Plasmodium falciparum and relationship 
to malaria morbidity in Gambian children. Trans R Soc Trop Med Hyg. 
1990;84:648–57.
 15. Corran PH, O’Donnell RA, Todd J, Uthaipibull C, Holder AA, Crabb BS, et al. 
The fine specificity, but not the invasion inhibitory activity, of 19-kilo-
dalton merozoite surface protein 1-specific antibodies is associated 
with resistance to malarial parasitemia in a cross-sectional survey in The 
Gambia. Infect Immun. 2004;72:6185–9.
 16. Satoguina J, Walther B, Drakeley C, Nwakanma D, Oriero EC, Correa S, 
et al. Comparison of surveillance methods applied to a situation of low 
malaria prevalence at rural sites in The Gambia and Guinea Bissau. Malar 
J. 2009;8:274.
 17. Ord R, Alexander N, Dunyo S, Hallett R, Jawara M, Targett G, et al. Seasonal 
carriage of pfcrt and pfmdr1 alleles in Gambian Plasmodium falciparum 
imply reduced fitness of chloroquine-resistant parasites. J Infect Dis. 
2007;196:1613–9.
 18. Kirby MJ, Ameh D, Green C, Jawara M, Milligan PJ, Bottomley C, et al. Effi-
cacy of two different house screening interventions against exposure to 
malaria and anaemia in children in The Gambia: a randomized controlled 
trial. Lancet. 2009;374:998–1009.
 19. Riley EM, Jakobsen PH, Allen SJ, Wheeler JG, Bennett S, Jepsen S, et al. 
Immune response to soluble exoantigens of Plasmodium falciparum 
may contribute to both pathogenesis and protection in clinical malaria: 
evidence from a longitudinal, prospective study of semi-immune African 
children. Eur J Immunol. 1991;21:1019–25.
 20. Lulat A A study of humoral and cell-mediated immune responses to 
Plasmodium falciparum malaria gametocyte antigens in a rural Gambian 
population. PhD Thesis. London: London School of Hygiene and Tropical 
Medicine; 1993.
 21. Drakeley CJ, Akim NI, Sauerwein RW, Greenwood BM, Targett GA. Esti-
mates of the infectious reservoir of Plasmodium falciparum malaria in The 
Gambia and in Tanzania. Trans R Soc Trop Med Hyg. 2000;94:472–6.
 22. Ismaili J The role of ethnicity and immune responses to Plasmodium fal-
ciparum Antigens (MSP1-19, AMA1 and CSP) on malaria risk in a seasonal 
transmission area in The Gambia. MSc Thesis. London: London School of 
Hygiene and Tropical Medicine; 2007.
 23. Ceesay SJ, Koivogui L, Nahum A, Taal MA, Okebe J, Affara M, et al. Malaria 
prevalence among young infants in different transmission settings. Africa. 
Emerg Infect Dis. 2015;21:1114–21.
 24. Corran PH, Cook J, Lynch C, Leendertse H, Manjurano A, Griffin J, et al. 
Dried blood spots as a source of anti-malarial antibodies for epidemio-
logical studies. Malar J. 2008;7:195.
 25. Okebe J, Affara M, Correa S, Muhammad AK, Nwakanma D, Drakeley 
C, et al. School-Based countrywide seroprevalence survey reveals 
spatial heterogeneity in malaria transmission in the Gambia. PLoS One. 
2014;9:e110926.
 26. Griffin J. REVCAT Stata module to fit reversible catalytic models. Boston: 
Boston College Department of Economics; 2015 [Statistical Software 
Components].
 27. Corran P, Coleman P, Riley E, Drakeley C. Serology: a robust indicator of 
malaria transmission intensity? Trends Parasitol. 2007;23:575–82.
Page 10 of 10van den Hoogen et al. Malar J  (2015) 14:416 
 28. Jasseh M, Webb EL, Jaffar S, Howie S, Townend J, Smith PG, et al. Reaching 
millennium development goal 4—The Gambia. Trop Med Int Health. 
2011;16:1314–25.
 29. Stresman GH, Stevenson JC, Ngwu N, Marube E, Owaga C, Drakeley C, 
et al. High Levels of asymptomatic and subpatent Plasmodium falci-
parum parasite carriage at health facilities in an area of heterogeneous 
malaria transmission intensity in the Kenyan Highlands. Am J Trop Med 
Hyg. 2014;91:1101–8.
 30. Trape J-F, Tall A, Sokhna C, Ly AB, Diagne N, Ndiath O, et al. The rise 
and fall of malaria in a west African rural community, Dielmo, Senegal, 
from 1990 to 2012: a 22 year longitudinal study. Lancet Infect Dis. 
2014;14:476–88.
 31. Sepúlveda N, Drakeley C. Sample size determination for estimating 
antibody seroconversion rate under stable malaria transmission intensity. 
Malar J. 2015;14:141.
 32. Wong J, Hamel MJ, Drakeley CJ, Kariuki S, Shi YP, Lal AA, et al. Serologi-
cal markers for monitoring historical changes in malaria transmission 
intensity in a highly endemic region of Western Kenya, 1994–2009. Malar 
J. 2014;13:451.
 33. White MT, Griffin JT, Akpogheneta O, Conway DJ, Koram KA, Riley EM, 
et al. Dynamics of the antibody response to Plasmodium falciparum 
infection in African children. J Infect Dis. 2014;210:1115–22.
 34. Oduro AR, Conway DJ, Schellenberg D, Satoguina J, Greenwood BM, 
Bojang KA. Seroepidemiological and parasitological evaluation of the 
heterogeneity of malaria infection in the Gambia. Malar J. 2013;12:222.
 35. Kilama M, Smith DL, Hutchinson R, Kigozi R, Yeka A, Lavoy G, et al. 
Estimating the annual entomological inoculation rate for Plasmodium 
falciparum transmitted by Anopheles gambiae s.l. using three sampling 
methods in three sites in Uganda. Malar J. 2014;13:111.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
